A concise promoter region of the heart fatty acid-binding protein gene dictates tissue-appropriate expression

Circulation Research

Volumn 84, Issue 3, 1999, Pages 276-289

  Qian, Qinghua ^a   Kuo, Lyn ^a   Yu, Yie Teh ^a   Rottman, Jeffrey N ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty acid binding protein; Myocyte; Promoter region; Transgene

Indexed keywords

FATTY ACID BINDING PROTEIN;

ANIMAL TISSUE; ARTICLE; DNA DETERMINATION; DNA SEQUENCE; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TATA BOX; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 0033046274     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.3.276     Document Type: Article

References (73)

1. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol. 1974;36:413-459.
2. Offner GD, Troxler RF, Brecher P. Characterization of a fatty acid binding protein from rat heart. J Biol Chem. 1986;261:5584-5589.
3. Paulussen RJA, Van der Logt CPE, Veerkamp JH. Characterization and binding properties of fatty acid-binding proteins from human, pig, and rat heart. Arch Biochem Biophys. 1988;264:533-545.
4. Unterberg C, Heidl G, Bassewitz VDB, Spener F. Isolation and characterization of the fatty acid binding protein from human heart. J Lipid Res. 1986;27:1287-1293.
5. Veerkamp JH, Peeters RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta. 1991;1081:1-24.
6. Demmer LA, Birkenmeier EH, Sweetser DA, Levin MS, Zollman S, Sparkes RS, Mohandas T, Lusis AJ, Gordon JI. The cellular retinol binding protein II gene-sequence analysis of the rat gene, chromosomal localization in mice and humans, and documentation of its close linkage to the cellular retinol binding protein gene. J Biol Chem. 1987;262: 2458-2467.
7. Green RP, Cohn SM, Sacchettini JC, Jackson KE, Gordon JI. The mouse intestinal fatty acid binding protein gene: nucleotide sequence, pattern of developmental and regional expression, and proposed structure of its protein product. DNA Cell Biol. 1992;11:31-41.
8. Hayasaka K, Himoro M, Takada G, Takahashi E-I, Minishima S, Shimizu N. Structure and localization of the gene encoding human peripheral myeline protein 2. Genomics. 1993;18:244-248.
9. Hunt CR, Ro JHS, Dobson DE, Min HY, Spiegelman BM. Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat-cell specific genes. Proc Natl Acad Sci U S A. 1986;83: 3786-3790.
10. Nilsson MHL, Spurr NK, Lundvall J, Rask L, Peterson PA. Human cellular retinol-binding protein gene organization and chromosomal location. Eur J Biochem. 1988;173:35-44.
11. Sweetser DA, Lowe JB, Gordon JI. The nucleotide sequence of the rat liver fatty acid-binding protein gene. J Biol Chem. 1986;261:5553-5561.
12. Sweetser DA, Birkenmeier EH, Klisak IJ, Zollman S, Sparkes RS, Mohandas T, Lusis AJ, Gordon JI. The human and rodent intestinal fatty acid binding protein genes: a comparative analysis of their structure, expression, and linkage relationships. J Biol Chem. 1987;262: 16060-16071.
13. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou UE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274:1377-1379.
14. Claffey KP, Herrera VL, Brecher P, Ruiz-Opazo N. Cloning and tissue distribution of rat heart fatty acid binding protein mRNA: identical forms in heart and skeletal muscle. Biochemistry. 1987;26:7900-7904.
15. Heukeroth RO, Birkenmeier EH, Levin MS, Gordon JI. Analysis of the tissue-specific expression and developmental regulation, and linkage relationships of a rodent gene encoding heart fatty acid binding protein. J Biol Chem. 1987;262:9709-9717.
16. Paulussen RJA, Geelen MJH, Beynen AC, Veerkamp JH. Immunochemical quantification of fatty acid binding proteins. I: tissue and intracellular distribution, postnatal development and influence of physiological conditions on rat heart and liver FABP. Biochim Biophys Acta. 1989;1001:201-209.
17. Veerkamp JH, Paulussen RJA, Peeters RA, Maatman RGHJ, Van Moerkert HTB, Van Kuppevelt TH. Detection, tissue distribution, and (sub)cellular localization of fatty acid binding protein types. Mol Cell Biochem. 1990;98:11-18.
18. Watanabe K, Wakabayashi H, Veerkamp JH, Ono T, Suzuki T. Immunohistochemical distribution of heart-type fatty acid binding protein immunoreactivity in normal human tissues and acute myocardial infarction. J Pathol. 1993;170:59-65.
19. Bohmer FD, Kraft R, Otto A, Wemstedt C, Hellman U, Kurtz A, Muller T, Rohde K, Etzold G, Lehmann W, Langer P, Heldin C-H, Grosse R. Identification of a polypeptide growth inhibitor from bovine mammary gland. J Biol Chem. 1987;262:15137-15143.
20. Paulussen RJ, van Moerkerk HTB, Veerkamp JH. Immunochemical quantification of fatty acid-binding proteins: tissue distribution of liver and heart FABP types in human and porcine tissues. Int J Biochem. 1990;22:393-398.
21. Kaufmann M, Simoneau J-A, Veerkamp JH, Pette D. Electrostimulation-induced increases in fatty acid-binding protein and myoglobin in rat fast-twitch muscle and comparison with tissue levels in the heart. FEBS Lett. 1989;245:181-184.
22. van Breda E, Keizer HA, Vork MM, Surtel DA, Jong YFD, van der Vusse GJ, Glatz JF. Modulation of fatty acid-binding protein content of rat heart and muscle by endurance training and testosterone treatment. Pflugers Arch. 1992;421:274-279.
23. Veerkamp JH, van Moerkerk HTB. Fatty acid-bind protein and its relationship to fatty acid oxidation. Mol Cell Biochem. 1993;123:101-106.
24. Garnier A, Poizat C, Keriel C, Cuchet P, Vork MM, Jong YFd, Glatz JFC. Modulation of fatty acid-binding protein content of adult rat heart in response to chronic changes in plasma lipid levels. Mol Cell Biochem. 1993;123:107-112.
25. Glatz JFC, van Breda E, Keizer HA, Jong YFd, Lakey JRT, Rajotte RV, Thompson A, van der Vusse GJ, Lopaschuk GD. Rat heart fatty acid-binding protein is increased in experimental diabetes. Biochem Biophys Res Commun. 1994;199:639-646.
26. Grynberg A, Demaison L. Fatty acid oxidation in the heart. J Cardiovasc Pharmacol. 1996;28:S11-S17.
27. Gulick T, Pieper SJ, Murphey MA, Lange LG, Schreiner GF. A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of beta-adrenergic responses. Circulation. 1991;84:313-321.
28. Deryckere F, Gannon F. A one-hour minipreparation for extraction of DNA-binding proteins from animal tissues. Biotechniques. 1994;16:405.
29. Harris AN, Ruiz-Lozano P, Chen YF, Sionit P, Yu YT, Lilly B, Olson, EN, Chien KR. A novel A/T-rich element mediates ANF gene expression during cardiac myocyte hypertrophy. J Mol Cell Cardiol. 1997;29: 515-525.
30. Fickett JW. Coordinate positioning of MEF2 and myogenin binding sites. Gene. 1996;172:GC19-GC32.
31. Arlt MF, Goodfellow PJ, Rottman JN. Dinucleotide repeat in the third intron of the FABP3/MDGI gene. Dis Markers. 1996;13:57-59.
32. Peeters RA, Veerkamp JH, Geurts van Kessel A, Kanda T, Ono T. Cloning of the cDNA encoding human skeletal-muscle fatty-acid-binding protein: its peptide sequence, and chromosomal localization. Biochem J. 1991;276:203-207.
33. Karlin S, Altshul SF. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes. Proc Natl Acad Sci U S A. 1990;87:2264-2268.
34. Lawrence CE, Altshul SF, Boguski MS, Liu JS, Neuwald AF, Wootton JC. Detecting subtle sequence signals: a Gibbs sampling strategy for multiple alignment. Science. 1993;262:208-214.
35. Iannello RC, Mar JH, Ordahl CP. Characterization of a promoter element required for transcription in cardiac cells. J Biol Chem. 1991;266: 3309-3316.
36. Rottman JN, Gordon JI. Comparison of the patterns of expression of rat intestinal fatty acid binding protein/human growth hormone fusion genes in cultured intestinal epithelial cell lines and in the gut epithelium of transgenic mice. J Biol Chem. 1993;268:11994-12002.
37. Rump R, Buhlmann C, Borchers T, Spener F. Differentiation-dependent expression of heart type fatty acid binding protein in C2C12 muscle cells. Eur J Cell Biol. 1997;69:135-142.
38. Thompson WR, Nadal-Ginard B, Mahdavi V. A MyoD1-independent muscle-specific enhancer controls the expression of the beta-myosin heavy chain gene in skeletal and cardiac muscle cells. J Biol Chem. 1991;266:22678-22688.
39. Graves RA, Tontonoz P, Platt KA, Ross SR, Spiegelman BM. Identification of a fat cell enhancer: analysis of requirements for adipose tissue-specific gene expression. J Cell Biochem. 1992;49:219-224.
40. Gerbens F, Rettenberger G, Lenstra JA, Veerkamp JH, te Pas MF. Characterization, chromosomal localization, and genetic variation of the porcine heart fatty acid binding protein gene. Mamm Genome. 1997;8: 328-332.
41. Nurrish SJ, Treisman R. DNA binding specificity determinants in MADS-box transcription factors. Mol Cell Biol. 1995;15:4076-4085.
42. Pollack R, Treisman R. Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J. 1992;11:4631-4640.
43. Lee TC, Shi Y, Schwartz RJ. Displacement of BrdU-induced YY1 by serum response factor activates skeletal alpha-actin transcription in embryonic myoblasts. Proc Natl Acad Sci U S A. 1992;89:9814-9818.
44. Chen CY, Schwartz RJ. Competition between negative acting YY1 vs. positive acting serum response factor and tinman homologue nkx-2.5 regulates cardiac α-actin promoter activity. Mol Endocrinol. 1997;11: 812-822.
45. Martin KA, Gualberto A, Kolman MF, Lowry J, Walsh K. A competitive mechanism of CArG element regulation by YY1 and SRF: implications for assessment of Phox1/MHox transcription factor interactions at CArG elements. DNA Cell Biol. 1997;16:653-661.
46. Hill CS, Wynne J, Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activity by SRF. Cell. 1995;81: 1159-1170.
47. Sealy L, Malone D, Pawlak M. Regulation of the cfos serum response element by C/EBPbeta. Mol Cell Biol. 1997;17:1744-1755.
48. Fickett JW. Quantitative discrimination of MEF2 sites. Mol Cell Biol. 1996;16:437-441.
49. Grayson J, Williams RS, Yu Y-T, Bassel-Duby R. Synergistic interactions between heterologous upstream activation elements and specific TATA sequences in a muscle-specific promoter. Mol Cell Biol. 1995;15: 1870-1878.
50. Qin W, Khuchua Z, Klein SC, Strauss AW. Elements regulating cardiomyocyte expression of the human sarcomeric mitochondrial creatine kinase gene in transgenic mice. J Biol Chem. 1997;272:25210-25216.
51. Kimura S, Abe K, Suzuki M, Ogawa M, Yoshioka K, Kaname T, Miike T, Yamamura K. A 900 bp genomic region from the mouse dystrophin promoter directs lacZ reporter expression only to the right heart of transgenic mice. Dev Growth Differ. 1997;39:257-265.
52. Franco D, Kelly R, Lamers WH, Buckingham M, Moorman AF. Regionalized transcription domains of myosin light chain 3f transgenes in the embryonic mouse heart: morphogenetic implications. Dev Biol. 1997; 188:17-33.
53. Haynes JI II, Duncan MK, Piatgorsky J. Spatial and temporal activity of the alpha B-crystallin/small heat shock protein gene promoter in transgenic mice. Dev Dyn. 1996;207:75-88.
54. Borchelt J, Davis J, Fischer M, Lee MK, Slunt HH, Rativitsky T, Regard J, Copeland NG, Jenkins NA, Sisodia SS, Price DL. A vector for expressing foreign genes in the brain and heart of transgenic mice. Genet Anal. 1996;13:159-163.
55. Disch DL, Rader TA, Cresci S, Leone TC, Barger PM, Vega R, Wood PA, Kelly DP. Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression. Mol Cell Biol. 1996;16:4043-4051.
56. Knotts S, Rindt H, Neumann J, Robbins J. In vivo regulation of the mouse beta myosin heavy chain gene. J Biol Chem. 1994;269:31275-31282.
57. Buttrick PM, Kaplan ML, Kitsis RN, Leinwand LA. Distinct behavior of cardiac myosin heavy chain gene constructs in vivo: discordance with in vitro results. Circ Res. 1993;76:1211-1217.
58. Jones WK, Sanchez A, Robbins J. Murine pulmonary myocardium: developmental analysis of cardiac gene expression. Dev Dyn. 1994;200: 117-128.
59. Lee Y, Nadal-Ginard B, Mahdavi V, Izumo S. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the α-cardiac myosin heavy-chain gene. Mol Cell Biol. 1997;17: 2745-2755.
60. Kuisak R, Li H, Tran D, Capetanaki Y. A single mef2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis. Dev Biol. 1996;174:1-13.
61. Ross RS, Navankasattusas S, Harvey RP, Chien KR. An HL-1a/HF-1b/MEF2 combinatorial element confers cardiac ventricular specificity and established an anterior-posterior gradient of expression. Development. 1996;122:1799-1809.
62. McGrew MJ, Bogdanova N, Hasegawa K, Hughes SH, Kitsis RN, Rosenthal N. Distinct gene expression patterns in skeletal and cardiac muscle are dependent on common regulatory sequences in the MLC1/3 locus. Mol Cell Biol. 1996;16:4524-4534.
63. Salminen M, Spitz F, Fiszman MY, Demignan J, Kahn A, Daegelen D, Maire P. Myotube-specific activity of the human aldolase A M-promoter requires an overlapping binding site for NF1 and MEF2 factors in addition to a binding site (M1) for an unknown protein. J Mol Biol. 1995;253:17-31.
64. Wan B, Moreadith RW. Structural characterization and regulatory element analysis of the heart isoform of cytochrome c oxidase Vla. J Biol Chem. 1995;270:26433-26440.
65. Liu ML, Olsen AL, Edgington NP, Moye-Rowley WS, Pessin JE. Myocyte-enhancer factor 2 (mef2) binding site is essential for C2C12 myotube-specific expression of the rat GLUT4/muscle-adipocyte facilitative glucose transporter gene. J Biol Chem. 1994;269: 28514-28521.
66. Cserjesi P, Lilly B, Hinkley C, Perry M, Olson EN. Homeodomain protein MHox and MADS protein myocyte enhancer-binding factor-2 converge on a common element in the muscle creatine kinase enhancer. J Biol Chem. 1994;269:16740-16745.
67. Amacher SL, Bustein JW, Hauschka SD. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol Cell Biol. 1993;13:2753-2764.
68. Leone TC, Cresci S, Carter ME, Zhang Z, Lala DS, Strauss AW, Kelly DP. The human medium chain acyl-CoA dehydrogenase gene promoter consists of a complex arrangement of nuclear receptor response elements and Sp1 binding sites. J Biol Chem. 1995;270:16308-16314.
69. Sack MN, Disch DL, Rockman HA, Kelly DP. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci USA. 1997;94:6438-6443.
70. Vinals F, Fandos C, Santalucia T, Ferre J, Testar X, Palacin M, Zorzano A. Myogenesis and MyoD down-regulate Sp1: a mechanism for the repression of GLUT1 during muscle cell differentiation. J Biol Chem. 1997;272:12913-12921.
71. Sladek R, Bader J, Giguere V. The orphan nuclear receptor estrogen-related receptor α is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol Cell Biol. 1997;17:5400-5409.
72. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res. 1996;37:907-925.
73. Chen CY, Schwartz RJ. Identification of novel DNA binding targets and regulatory domains of a murine tinman homeodomain factor, nkx-2.5. J Biol Chem. 1995;270:15628-15633.